Clovis Oncology Announces Proposed Offering of Common Stock

BOULDER, Colo.–(BUSINESS WIRE)–Clovis Oncology, Inc. (NASDAQ:CLVS) announced today that it has commenced an underwritten public offering of shares of its common stock to raise aggregate proceeds of approximately $250 million. All shares of the common stock to be sold in the offering will be offered by Clovis Oncology. Clovis Oncology intends to use the net proceeds of the offering for general corporate purposes, including sales and marketing expenses associated with Rubraca┬« (rucaparib) in th
Source: BusinessWire-Primary

Clovis Oncology Announces Proposed Offering of Common Stock